Update on CSF Biomarkers in Parkinson’s Disease

Progress in developing disease-modifying therapies in Parkinson’s disease (PD) can only be achieved through reliable objective markers that help to identify subjects at risk. This includes an early and accurate diagnosis as well as continuous monitoring of disease progression and therapy response. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Eun Hae, Tennagels, Sabrina, Gold, Ralf, Gerwert, Klaus, Beyer, Léon, Tönges, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869235/
https://www.ncbi.nlm.nih.gov/pubmed/35204829
http://dx.doi.org/10.3390/biom12020329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869235/
https://www.ncbi.nlm.nih.gov/pubmed/35204829
http://dx.doi.org/10.3390/biom12020329

Ejemplares similares